Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.
OBJECTIVE:The molecular determinants of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) remain poorly understood. The receptor for advanced glycation endproducts (RAGE) and its ligands: HMGB1 and S100A9 are involved in inflammatory disorder...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4154707?pdf=render |
id |
doaj-811835498fb44929962af2928f749dbd |
---|---|
record_format |
Article |
spelling |
doaj-811835498fb44929962af2928f749dbd2020-11-25T00:05:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10644010.1371/journal.pone.0106440Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.Bernhard MoserAnna MegerleChristine BekosStefan JanikTamás SzerafinPeter BirnerAna-Iris SchieferMichael MildnerIrene LangNika Skoro-SajerRoela Sadushi-KoliciShahrokh TaghaviWalter KlepetkoHendrik Jan AnkersmitOBJECTIVE:The molecular determinants of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) remain poorly understood. The receptor for advanced glycation endproducts (RAGE) and its ligands: HMGB1 and S100A9 are involved in inflammatory disorders. We sought to investigate the role of the RAGE axis in patients with CTEPH undergoing pulmonary endarterectomy (PEA), iPAH undergoing lung transplantation (LuTX). The high pulmonary vascular resistance in CTEPH/iPAH results in pressure overload of the right ventricle. We compared sRAGE measurements to that of patients with aortic valve stenosis (AVS) - pressure overload of the left ventricle. METHODS:We enrolled patients with CTEPH(26), iPAH(15), AVS(15) and volunteers(33). Immunohistochemistry with antibodies to RAGE and HMGB1 was performed on PEA specimens and lung tissues. We employed enzyme-linked immunosorbent assays to determine the concentrations of sRAGE, esRAGE, HMGB1 and S100A9 in serum of volunteers and patients with CTEPH, iPAH, AVS before and after PEA, LuTX and aortic valve replacement (AVR). RESULTS:In endarterectomised tissues from patients with CTEPH RAGE and HMGB1 were identified in myofibroblasts (α-SMA+vimentin+CD34-), recanalizing vessel-like structures of distal myofibrotic tissues and endothelium of neointima. RAGE was differentially expressed in prototypical Heath Edwards lesions in iPAH. We found significantly increased serum concentrations of sRAGE, esRAGE and HMGB1 in CTEPH. In iPAH, sRAGE and esRAGE were significantly higher than in controls. Serum concentrations of sRAGE were significantly elevated in iPAH(p<0.001) and CTEPH(p = 0.001) compared to AVS. Serum sRAGE was significantly higher in iPAH compared to CTEPH(p = 0.042) and significantly reduced in AVS compared to controls(p = 0.001). There were no significant differences in sRAGE serum concentrations before and after surgical therapy for CTEPH, iPAH or AVS. CONCLUSIONS:Our data suggest a role for the RAGE pathway in the pathophysiology of CTEPH and iPAH. PEA improves the local control of disease but may not influence the systemic inflammatory mechanisms in CTEPH patients through the RAGE pathway.http://europepmc.org/articles/PMC4154707?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bernhard Moser Anna Megerle Christine Bekos Stefan Janik Tamás Szerafin Peter Birner Ana-Iris Schiefer Michael Mildner Irene Lang Nika Skoro-Sajer Roela Sadushi-Kolici Shahrokh Taghavi Walter Klepetko Hendrik Jan Ankersmit |
spellingShingle |
Bernhard Moser Anna Megerle Christine Bekos Stefan Janik Tamás Szerafin Peter Birner Ana-Iris Schiefer Michael Mildner Irene Lang Nika Skoro-Sajer Roela Sadushi-Kolici Shahrokh Taghavi Walter Klepetko Hendrik Jan Ankersmit Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. PLoS ONE |
author_facet |
Bernhard Moser Anna Megerle Christine Bekos Stefan Janik Tamás Szerafin Peter Birner Ana-Iris Schiefer Michael Mildner Irene Lang Nika Skoro-Sajer Roela Sadushi-Kolici Shahrokh Taghavi Walter Klepetko Hendrik Jan Ankersmit |
author_sort |
Bernhard Moser |
title |
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. |
title_short |
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. |
title_full |
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. |
title_fullStr |
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. |
title_full_unstemmed |
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. |
title_sort |
local and systemic rage axis changes in pulmonary hypertension: cteph and ipah. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
OBJECTIVE:The molecular determinants of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) remain poorly understood. The receptor for advanced glycation endproducts (RAGE) and its ligands: HMGB1 and S100A9 are involved in inflammatory disorders. We sought to investigate the role of the RAGE axis in patients with CTEPH undergoing pulmonary endarterectomy (PEA), iPAH undergoing lung transplantation (LuTX). The high pulmonary vascular resistance in CTEPH/iPAH results in pressure overload of the right ventricle. We compared sRAGE measurements to that of patients with aortic valve stenosis (AVS) - pressure overload of the left ventricle. METHODS:We enrolled patients with CTEPH(26), iPAH(15), AVS(15) and volunteers(33). Immunohistochemistry with antibodies to RAGE and HMGB1 was performed on PEA specimens and lung tissues. We employed enzyme-linked immunosorbent assays to determine the concentrations of sRAGE, esRAGE, HMGB1 and S100A9 in serum of volunteers and patients with CTEPH, iPAH, AVS before and after PEA, LuTX and aortic valve replacement (AVR). RESULTS:In endarterectomised tissues from patients with CTEPH RAGE and HMGB1 were identified in myofibroblasts (α-SMA+vimentin+CD34-), recanalizing vessel-like structures of distal myofibrotic tissues and endothelium of neointima. RAGE was differentially expressed in prototypical Heath Edwards lesions in iPAH. We found significantly increased serum concentrations of sRAGE, esRAGE and HMGB1 in CTEPH. In iPAH, sRAGE and esRAGE were significantly higher than in controls. Serum concentrations of sRAGE were significantly elevated in iPAH(p<0.001) and CTEPH(p = 0.001) compared to AVS. Serum sRAGE was significantly higher in iPAH compared to CTEPH(p = 0.042) and significantly reduced in AVS compared to controls(p = 0.001). There were no significant differences in sRAGE serum concentrations before and after surgical therapy for CTEPH, iPAH or AVS. CONCLUSIONS:Our data suggest a role for the RAGE pathway in the pathophysiology of CTEPH and iPAH. PEA improves the local control of disease but may not influence the systemic inflammatory mechanisms in CTEPH patients through the RAGE pathway. |
url |
http://europepmc.org/articles/PMC4154707?pdf=render |
work_keys_str_mv |
AT bernhardmoser localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT annamegerle localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT christinebekos localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT stefanjanik localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT tamasszerafin localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT peterbirner localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT anairisschiefer localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT michaelmildner localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT irenelang localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT nikaskorosajer localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT roelasadushikolici localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT shahrokhtaghavi localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT walterklepetko localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah AT hendrikjanankersmit localandsystemicrageaxischangesinpulmonaryhypertensionctephandipah |
_version_ |
1725423488287637504 |